Global Oncology Ablation Market to Reach $801.3 Million by 2020
Increasing ageing population across the globe, technological advancements, rising adoption of these technologies, increasing demand for minimally invasive procedures, and rising risk factors including lifestyle disorders are the major factors which are driving global oncology ablation market. However, high cost of the treatment and various pharmaceutical advancements restrains the market to a certain extent.
Wembley, United Kingdom, September 18, 2014 --(PR.com)-- The research report titled “Global Oncology Ablation Market Outlook: 2014-2020” analyzes the major drivers, restraints, opportunities, and challenges that have a long and short-term impact on the growth of oncology ablation market across the globe. This latest release from Meticulous Research states that, the global oncology ablation market would reach $801.3 million by 2020 with a CAGR of 9.3% over the period of 2014 to 2020.
Oncology Ablation market is segmented by cancer type, technology, and geography. The technologies analyzed in this report are Radiofrequency Ablation, Microwave Ablation, Cryoablation, Ethanol Ablation, Irreversible Electroporesis (IRE), Light (Laser Ablation), and Ultrasound. Radiofrequency ablation technology commands the largest share in the oncology ablation in 2014; whereas, microwave ablation is expected to grow at a highest CAGR during 2014 to 2020. The ablation procedures for various types of cancer such as liver cancer, prostate cancer, breast cancer, lung cancer, kidney cancer, and colorectal cancer are analyzed in the report.
Increasing ageing population across the globe, technological advancements, rising adoption of these technologies, increasing demand for minimally invasive procedures, and rising risk factors including lifestyle disorders are the major factors which are driving global oncology ablation market. However, high cost of the treatment and various pharmaceutical advancements restrains the market to a certain extent.
North America is the biggest market for oncology ablation as it has highest number of cancer diagnosed peoples. The growing aging population and the increased lifestyle disorders help to drive the European oncology ablation market. On the other hand, Asia Pacific region significant opportunities for oncology ablation market mainly due to an increasing awareness of the technologically advanced products and healthcare reforms in his region. Moreover, an improved government approach towards the healthcare facilities further propels the market in this region.
The report elucidates on many various important aspects of the global oncology ablation market that facilitate the understanding of this market at a granular level. The prominent players in the oncology ablation market are AngioDynamics (U.S.), Covidien (Ireland), Boston Scientific (U.S.), BSD Medical (U.S.), Galil Medical (U.S.), Misonix (U.S), Varian Medical Systems (U.S), Elekta AB (Sweden), Accuray .(U.S), HealthTronics (U.S.), Celon AG (Germany), NeuWave Medical (U.S.), SonaCare Medical (U.S), RF Medical Co. (Korea), STARMed Co. (Korea), and APRO KOREA (Korea) with detailed analysis of their product portfolio, financials, and recent developments.
About Meticulous Research
We are Meticulous. We are one of the leading market research and consulting company focusing on medical devices, biotechnology, healthcare IT, pharmaceuticals, food and beverages, and agriculture domains. We provide solutions to our clients through our market research support, data management services & advanced analytical skills. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation and analysis of data including qualitative and quantitative research with the finest team of analysts.
We focus on client satisfaction by delivering excellent market research solutions which help organizations to adapt, sustain, and grow in the changing business environment.
Contact:
sales@meticulousresearch.com
Visit: http://www.meticulousresearch.com/
Oncology Ablation market is segmented by cancer type, technology, and geography. The technologies analyzed in this report are Radiofrequency Ablation, Microwave Ablation, Cryoablation, Ethanol Ablation, Irreversible Electroporesis (IRE), Light (Laser Ablation), and Ultrasound. Radiofrequency ablation technology commands the largest share in the oncology ablation in 2014; whereas, microwave ablation is expected to grow at a highest CAGR during 2014 to 2020. The ablation procedures for various types of cancer such as liver cancer, prostate cancer, breast cancer, lung cancer, kidney cancer, and colorectal cancer are analyzed in the report.
Increasing ageing population across the globe, technological advancements, rising adoption of these technologies, increasing demand for minimally invasive procedures, and rising risk factors including lifestyle disorders are the major factors which are driving global oncology ablation market. However, high cost of the treatment and various pharmaceutical advancements restrains the market to a certain extent.
North America is the biggest market for oncology ablation as it has highest number of cancer diagnosed peoples. The growing aging population and the increased lifestyle disorders help to drive the European oncology ablation market. On the other hand, Asia Pacific region significant opportunities for oncology ablation market mainly due to an increasing awareness of the technologically advanced products and healthcare reforms in his region. Moreover, an improved government approach towards the healthcare facilities further propels the market in this region.
The report elucidates on many various important aspects of the global oncology ablation market that facilitate the understanding of this market at a granular level. The prominent players in the oncology ablation market are AngioDynamics (U.S.), Covidien (Ireland), Boston Scientific (U.S.), BSD Medical (U.S.), Galil Medical (U.S.), Misonix (U.S), Varian Medical Systems (U.S), Elekta AB (Sweden), Accuray .(U.S), HealthTronics (U.S.), Celon AG (Germany), NeuWave Medical (U.S.), SonaCare Medical (U.S), RF Medical Co. (Korea), STARMed Co. (Korea), and APRO KOREA (Korea) with detailed analysis of their product portfolio, financials, and recent developments.
About Meticulous Research
We are Meticulous. We are one of the leading market research and consulting company focusing on medical devices, biotechnology, healthcare IT, pharmaceuticals, food and beverages, and agriculture domains. We provide solutions to our clients through our market research support, data management services & advanced analytical skills. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation and analysis of data including qualitative and quantitative research with the finest team of analysts.
We focus on client satisfaction by delivering excellent market research solutions which help organizations to adapt, sustain, and grow in the changing business environment.
Contact:
sales@meticulousresearch.com
Visit: http://www.meticulousresearch.com/
Contact
Meticulous Research
John Pitt
918055561003
www.meticulousresearch.com/
John Pitt
918055561003
www.meticulousresearch.com/
Contact
Categories